Login
$ELTX
$1.83 +$0.13 (7.65%) Close

$ELTX 4 SEC Filings

Filed On Filing
02 Sep 2026 Form 4: Adams Julian, Director

Granted 21,750 Stock Option (Right to Buy)

02 Sep 2026 Form 4: Ashe Carol Gail, Director

Granted 21,750 Stock Option (Right to Buy)

02 Sep 2026 Form 4: Chudnovsky Yekaterina, Director

Granted 21,750 Stock Option (Right to Buy)

02 Sep 2026 Form 4: Nissenson Allen, Director

Granted 21,750 Stock Option (Right to Buy)

02 Sep 2026 Form 4: Ruffolo Robert R, Director

Granted 21,750 Stock Option (Right to Buy)

02 Sep 2026 Form 4: Wilson Karen J, Director

Granted 21,750 Stock Option (Right to Buy)

02 Sep 2026 Form 4: Venkatesan Jay, Director

Granted 21,750 Stock Option (Right to Buy)

17 Jul 2026 Form 4: Haqq Christopher, See Remarks

Granted 64,643 Stock Option (Right to Buy)

17 Jul 2026 Form 4: DeMuth Peter, Chief Scientific Officer

Granted 52,832 Stock Option (Right to Buy)

17 Jul 2026 Form 4: Shah Preetam, See Remarks

Granted 60,833 Stock Option (Right to Buy)

17 Jul 2026 Form 4: Connelly Robert, Director

Granted 186,944 Stock Option (Right to Buy)

03 Feb 2026 Form 4: Connelly Robert, Director

Received 73,600 shares as a grant or award · Granted 147,200 Stock Option (Right to Buy)

03 Feb 2026 Form 4: Shah Preetam, See Remarks

Received 24,000 shares as a grant or award · Granted 47,900 Stock Option (Right to Buy)

03 Feb 2026 Form 4: DeMuth Peter, Chief Scientific Officer

Received 20,800 shares as a grant or award · Granted 41,600 Stock Option (Right to Buy)

03 Feb 2026 Form 4: Haqq Christopher, See Remarks

Received 25,400 shares as a grant or award · Granted 50,900 Stock Option (Right to Buy)

10 Dec 2025 Form 4: DeMuth Peter, Chief Scientific Officer

Received 362 shares by exercise or conversion ($1.6K)

04 Jun 2025 Form 4: Chudnovsky Yekaterina, Director and 1 other

Granted 103,225 Warrant (right to buy)

20 May 2025 Form 4: Ashe Carol Gail, Director

Granted 7,900 Stock Option (Right to Buy)

20 May 2025 Form 4: Nissenson Allen, Director

Granted 7,900 Stock Option (Right to Buy)

20 May 2025 Form 4: Venkatesan Jay, Director

Granted 7,900 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support